1076 related articles for article (PubMed ID: 34336425)
1. Rare and Complicated Overlap of Stevens-Johnson Syndrome and Acute Generalized Exanthematous Pustulosis.
Chowdhury TA; Talib KA; Patricia J; Nye KD; Moosa SA
Cureus; 2021 Jun; 13(6):e15921. PubMed ID: 34336425
[TBL] [Abstract][Full Text] [Related]
2. Severe flucloxacillin-induced acute generalized exanthematous pustulosis (AGEP), with toxic epidermal necrolysis (TEN)-like features: does overlap between AGEP and TEN exist? Clinical report and review of the literature.
van Hattem S; Beerthuizen GI; Kardaun SH
Br J Dermatol; 2014 Dec; 171(6):1539-45. PubMed ID: 24888401
[TBL] [Abstract][Full Text] [Related]
3. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
[TBL] [Abstract][Full Text] [Related]
4. Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?
Bouvresse S; Valeyrie-Allanore L; Ortonne N; Konstantinou MP; Kardaun SH; Bagot M; Wolkenstein P; Roujeau JC
Orphanet J Rare Dis; 2012 Sep; 7():72. PubMed ID: 23009177
[TBL] [Abstract][Full Text] [Related]
5. A retrospective, 5-year, clinicoepidemiological study of severe cutaneous adverse reactions (SCARs).
Singh GK; Mitra B; Arora S; Akhoon N; Verma R; Sharma P; Mitra D
Int J Dermatol; 2021 May; 60(5):579-588. PubMed ID: 33454956
[TBL] [Abstract][Full Text] [Related]
6. Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: case presentation and literature review.
Copaescu AM; Bouffard D; Masse MS
Allergy Asthma Clin Immunol; 2020; 16():9. PubMed ID: 32042284
[TBL] [Abstract][Full Text] [Related]
7. Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: a case report and review of the literature.
Peermohamed S; Haber RM
Arch Dermatol; 2011 Jun; 147(6):697-701. PubMed ID: 21690532
[TBL] [Abstract][Full Text] [Related]
8. Severe acute generalized exanthematous pustulosis with toxic epidermal necrolysis-like desquamation: A case series of 8 patients.
Huang S; Ahmed A; Hsu S; Lee J; Motaparthi K
JAAD Case Rep; 2021 Sep; 15():115-122. PubMed ID: 34466647
[No Abstract] [Full Text] [Related]
9. Severe cutaneous adverse reactions: A 5-year retrospective study at Hospital Melaka, Malaysia, from December 2014 to February 2020.
Tee CT; Abdullah NH; Kristummoonthy P; Lee CS
Med J Malaysia; 2022 Jul; 77(4):409-414. PubMed ID: 35902928
[TBL] [Abstract][Full Text] [Related]
10. Paracetamol (Acetaminophen)-associated SJS, TEN, AGEP, and DRESS Syndromes - A Narrative Review.
Pakkir Maideen NM; Barakat IR; Jumale AH
Curr Drug Saf; 2024; 19(2):218-223. PubMed ID: 37151075
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and prognostic factors of severe cutaneous adverse drug reactions: A single-center retrospective study of 209 cases in China.
Deng M; Su Y; Wu R; Li S; Tang G; Kuang Q; Luo X; Zhu Y; Shen W
Int Immunopharmacol; 2023 Jan; 114():109530. PubMed ID: 36508915
[TBL] [Abstract][Full Text] [Related]
12. Severe Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Saudi Arabia.
AlJasser MI
Dermatol Res Pract; 2023; 2023():8928198. PubMed ID: 37206671
[TBL] [Abstract][Full Text] [Related]
13. Severe cutaneous adverse drug reactions: incidence, clinical characteristics, treatment, and outcome in pediatric patients.
Na Bangxang P; Wisuthsarewong W; Nitiyarom R
Asian Pac J Allergy Immunol; 2024 Jan; ():. PubMed ID: 38183639
[TBL] [Abstract][Full Text] [Related]
14. Acute generalized exanthematous pustulosis simulating Stevens-Johnson syndrome/toxic epidermal necrolysis associated with the use of vismodegib.
Moreno-Arrones OM; Carrillo-Gijon R; Sendagorta E; Rios-Buceta L
JAAD Case Rep; 2018 Mar; 4(2):123-125. PubMed ID: 29387760
[No Abstract] [Full Text] [Related]
15. Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System.
Godfrey H; Jedlowski P; Thiede R
Australas J Dermatol; 2024 May; 65(3):243-253. PubMed ID: 38572842
[TBL] [Abstract][Full Text] [Related]
16. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting.
Liccioli G; Mori F; Parronchi P; Capone M; Fili L; Barni S; Sarti L; Giovannini M; Resti M; Novembre EM
Clin Exp Allergy; 2020 Jan; 50(1):61-73. PubMed ID: 31608511
[TBL] [Abstract][Full Text] [Related]
17. Severe cutaneous adverse reactions in a tertiary care center in Jamaica.
McNish AJS; Ho JD; East-Innis ADC
JAAD Int; 2024 Jun; 15():139-146. PubMed ID: 38545494
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of BRAF/MEK inhibitors-induced Severe Cutaneous Adverse Reactions (SCARs).
Torres-Navarro I; de Unamuno-Bustos B; Botella-Estrada R
J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):607-614. PubMed ID: 32846030
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced severe cutaneous adverse reactions: Determine the cause and prevention.
Zhang C; Van DN; Hieu C; Craig T
Ann Allergy Asthma Immunol; 2019 Nov; 123(5):483-487. PubMed ID: 31400461
[TBL] [Abstract][Full Text] [Related]
20. Medication Associations With Severe Cutaneous Adverse Reactions: A Case/Non-Case Analysis Using the FDA Adverse Event Reporting System.
Godfrey H; Jedlowski P; Thiede R
J Cutan Med Surg; 2024; 28(1):51-58. PubMed ID: 38189282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]